“Junk DNA” Provides Surprising New Treatments for Hard-To-Treat Blood Cancers
Researchers at King’s College London have uncovered a surprising vulnerability in certain blood cancers by targeting a part…
Regular mammograms linked to longer survival in women over 80
For many older women, the question of whether to continue breast cancer screening has been uncertain. While most…
Reticulocalbin-1 in clear cell renal cell carcinoma: clinical and functional evidence for its role as a biomarker and potential therapeutic target | BMC Cancer
Despite therapeutic advancements, the prognosis for metastatic ccRCC remains poor, with a 5-year survival rate of approximately 12–20…
Preventing radiation damage with melanin-based material
Radiotherapy for abdominal and pelvic cancers almost always leads to small-intestine injuries that are difficult to heal,…
Expanding Patient Access to Comprehensive Genomic Profiling
Comprehensive genomic profiling (CGP) is reshaping cancer care by enhancing diagnostic accuracy, informing prognosis, and enabling more personalized…
Early ctDNA Status May Guide Consolidation Immunotherapy for Limited-Stage SCLC
Credit: Deep AI Measuring circulating tumor (ct) DNA after induction chemotherapy could identify the best candidates for consolidation…
Life-Saving Breast Cancer Drug Has a Rare but Serious Side Effect
Simplified representation of a uterine cancer cell. Credit: Svenja Kübler The findings challenge long-standing assumptions about therapy-related cancers.…
NYU Langone strengthens world-leading GI cancer program with renowned leaders
NYU Langone Health’s Perlmutter Cancer Center announces the arrival of acclaimed cancer leaders Anirban Maitra, MD, and Manuel…